Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells
Authors
Ana Reis-Mendes
Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
Marisa Alves
Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
Félix Carvalho
Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
Fernando Remião
Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
Maria Lourdes Bastos
Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
Vera Marisa Costa
Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
Language: English
Page range: 13 - 21
Submitted on: Feb 2, 2018
Accepted on: May 14, 2018
Published on: Aug 6, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2018 Ana Reis-Mendes, Marisa Alves, Félix Carvalho, Fernando Remião, Maria Lourdes Bastos, Vera Marisa Costa, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.